文献速递肝病

PBC-10:用于原发性胆汁性胆管炎临床筛查的简短生活质量量表

PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis.
PubMed 文献 · Aliment Pharmacol Ther · 2019-10-30

本研究基于UK-PBC研究队列中2219例完成PBC-40问卷的患者,通过逐步回归筛选出10个问题构成PBC-10简表,可解释PBC-40评分变异的95%以上。

要点

  • PBC-10是由PBC-40简化而来的10条目生活质量问卷,适用于临床实践中的常规症状筛查。
  • PBC-10评分变化4分被视为具有临床重要差异。

核心结论

  • PBC-10是评估原发性胆汁性胆管炎患者健康相关生活质量的简短有效问卷,适合临床实践使用。

研究设计与样本

  • 基于UK-PBC研究队列,分析2013年2219例完成PBC-40问卷的患者数据,通过逐步回归推导简表,并在2017年2502例患者中验证。
  • 另对186例患者进行重测信度、与EQ5D相关性及反应度分析,其中部分患者在2-4周内重复填写问卷。

主要发现

  • 逐步回归识别出10个问题,贡献了PBC-40评分变异的95%以上,覆盖PBC主要领域。
  • PBC-10内部一致性Cronbach's α为0.905,项目-总分相关性良好,无天花板效应但存在地板效应。
  • 2017年2502例患者验证确认了PBC-10的心理测量学特性。
  • PBC-10评分变化4分被视为具有临床重要性。

关键数值与推荐

  • PBC-10包含10个条目,可解释PBC-40评分变异的95%以上。
  • 内部一致性Cronbach's α为0.905(推导队列)和0.936(验证亚组)。
  • 临床重要变化阈值为4分。

临床怎么用

  • PBC-10可作为原发性胆汁性胆管炎患者生活质量的简短筛查工具,用于临床常规症状评估。
  • 评分变化达到4分时提示具有临床意义的改变,可辅助临床决策。

局限性

  • PBC-10存在地板效应,可能影响对低症状负担患者的区分能力。
  • 验证主要基于UK-PBC研究队列,外部人群的适用性需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines in primary biliary cholangitis ( PBC) recommend routine screening for symptoms. However, at present there are no validated practical tools suitable for screening use in practice. AIM: To develop a short quality of life questionnaire for PBC METHODS: The short PBC HRQL questionnaire was derived and validated by analysing the PBC-40 questionnaires from the UK-PBC Research Cohort. Construct validity was assessed using the European Quality of Life Five Dimensions (EQ5D) questionnaire. Test-retest analysis was done by asking a subgroup of patients to complete the questionnaire twice within 2-4 weeks. RESULTS: A total of 2219 patients completed PBC-40 questionnaire in 2013. Stepwise regression identified 10 questions that contributed to more than 95% of the PBC-40 score variance and covered the main domains of PBC. The short HRQL questionnaire, PBC-10, had good internal consistency (Cronbach's α 0.905) and item-total correlations. PBC-10 demonstrated no ceiling effects but a floor effect was noted. Further validation on 2502 patients who completed the PBC questionnaire in 2017 confirmed the psychometric properties of PBC-10. Further analysis on 186 patients showed that PBC-10 demonstrated good internal consistency (Cronbach's α = 0.936), had good reproducibility (intra-class correlation coefficient = 0.945), good correlation with the EQ5D (r = .736), and was responsive to change. A change of 4 points in the PBC-10 score would be considered clinically important. CONCLUSION: PBC-10 is a short and valid questionnaire for assessing the HRQL in patients with PBC in clinical practice.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Alrubaiy L, Mells G, Flack S, et al. PBC-10: a short quality of life measure for clinical screening in primary biliary cholangitis. Aliment Pharmacol Ther. 2019. PMID: 31664722. doi:10.1111/apt.15554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。